What is BEIGF's health score?

BeOne Medicines Ltd. (BEIGF) has a TradeApes health score of 63 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BEIGF's estimated fair value?

Based on our 5-year discounted cash flow model, BeOne Medicines Ltd.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is BEIGF undervalued or overvalued?

Our model currently rates BEIGF as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BEIGF... Refresh in a moment for the full analysis.

BeOne Medicines Ltd. (BEIGF)

Healthcare Undervalued Medium healthy

Updated: 2026-04-21

TradeApes Score

hold

Financial Strength

90 Strong

Operating Trend

83 Strong

Relative Value

40 Weak

Capital Allocation

20 Stressed

Risk

70 Healthy

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.